Trial Details

RECRUITING
Basic Information
Clinical ID c769
Identifier NCT06073873
Trial Title A Post-Marketing Surveillance Study to Assess Safety of Ozanimod in Patients With Moderate to Severe Active UC in Korea
Trial URL Visit Original Page
Study Information
Study Results

NO
Conditions Ulcerative Colitis
Interventions DRUG: Ozanimod
Participant Information
Sponsor Bristol-Myers Squibb
City Seoul
Country/Region South Korea
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type OBSERVATIONAL
Phase NULL
Time Information
Start Date 2024-04-19
Primary Completion Date 2028-04-01
Completion Date 2028-04-01